Atea Pharmaceuticals, Inc.
AVIR
$3.75
$0.0752.04%
Headlines
3/27/2024
-
The Fly
3/27/2024
-
Globe Newswire
3/18/2024
-
Ticker Report
3/16/2024
-
Zolmax
3/6/2024
-
Zolmax
3/5/2024
-
Zolmax
2/29/2024
-
GuruFocus
2/29/2024
-
Seeking Alpha: Transcripts
2/29/2024
-
SeekingAlpha
2/29/2024
-
SeekingAlpha
2/28/2024
-
GuruFocus
2/28/2024
-
The Fly
2/28/2024
-
Globe Newswire
2/27/2024
-
Benzinga
2/26/2024
-
Ticker Report
2/21/2024
-
Globe Newswire
2/16/2024
-
Zolmax
2/9/2024
-
Zolmax
2/9/2024
-
Zolmax
2/7/2024
-
Ticker Report
2/5/2024
-
Zolmax
1/21/2024
-
Zolmax
1/9/2024
-
Benzinga
Filings
Wednesday, February 28, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
--
Business Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product...
more